Bradyarrhythmia after digitalis--chronic cardiotoxicity? 1980

G F Levi

UI MeSH Term Description Entries
D001919 Bradycardia Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK. Bradyarrhythmia,Bradyarrhythmias,Bradycardias
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G F Levi
May 1985, Journal of the American College of Cardiology,
G F Levi
January 1986, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement,
G F Levi
November 1980, Life sciences,
G F Levi
September 1982, American heart journal,
G F Levi
August 1962, The American journal of cardiology,
G F Levi
February 1969, Lancet (London, England),
G F Levi
November 1982, Research communications in chemical pathology and pharmacology,
G F Levi
January 1989, Basic research in cardiology,
G F Levi
May 2002, Deutsche medizinische Wochenschrift (1946),
G F Levi
August 1979, European journal of pharmacology,
Copied contents to your clipboard!